|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G16H 20/17 | (2018.01) |
| A61M 5/00 | (2006.01) | ||
| A61M 5/14 | (2006.01) | ||
| A61M 5/142 | (2006.01) |
| (11) | Patento numeris | 3164170 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15815601.8 |
| Europos patento paraiškos padavimo data | 2015-07-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/038843 |
| Data | 2015-07-01 |
| (87) | Numeris | WO 2016/004210 |
| Data | 2016-01-07 |
| (30) | Numeris | Data | Šalis |
| 201414320863 | 2014-07-01 | US |
| (72) |
ESTES, Mark C. , US
|
| (73) |
Bigfoot Biomedical, Inc. ,
1820 McCarthy Blvd, Milpitas, CA 95035,
US
|
| (54) | GLUCAGON ADMINISTRATION SYSTEM AND METHODS |
| GLUCAGON ADMINISTRATION SYSTEM AND METHODS |